Healthcare stocks were higher Tuesday afternoon, with the NYSE Healthcare Index rising 1.8% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 1.7%.
The iShares Biotechnology ETF (IBB) was up 0.8%.
In corporate news, Amylyx Pharmaceuticals (AMLX) shares surged nearly 55% after the company said Tuesday its investigational post-bariatric hypoglycemia treatment Avexitide met its primary endpoint in a phase 3 trial.